Lupus

Top Story

Gazyva receives FDA breakthrough therapy designation for lupus nephritis

Gazyva receives FDA breakthrough therapy designation for lupus nephritis
September 18, 2019

Read the Perspective from Gregg J. Silverman, MD

In the Journals

Infusion reactions to rituximab more significant in SLE than other diseases

September 17, 2019
Infusion reaction rates to rituximab may be more significant among patients with systemic lupus erythematosus than other diseases, according to findings published in…
In the Journals

Stress ‘primary driver’ for fatigue in patients with SLE

September 12, 2019
Although depression and stress are both predictors of fatigue among patients with systemic lupus erythematosus at 1 year, stress is the “primary driver,” and…
In the Journals

Hypertension, preeclampsia mediate adverse pregnancy outcomes in RA, SLE, psoriasis

August 29, 2019
Among patients with rheumatoid arthritis, systemic lupus erythematosus and psoriasis, the presence of hypertension or preeclampsia accounts for approximately 10% to 33%…
More Headlines »
CME ABIM MOC

Ace the Case: A 36-Year-Old Woman Presents With Generalized Pain, Easy Fatigability, Difficulty Staying Asleep, and Cognitive Difficulties for the Past 11 Months

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 36-year-old woman who presents with…
More »
Video
Meeting News

Lupus research takes center stage at ACR/ARHP annual meeting

October 24, 2018
More »
CME ABIM MOC

Ace the Case: A 5-Year-Old Girl Presents to the Office With Difficulty Walking

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 5-year-old girl with difficulty…
More »